Mark L. Bannister

766 total citations
17 papers, 601 citations indexed

About

Mark L. Bannister is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark L. Bannister has authored 17 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark L. Bannister's work include Ion channel regulation and function (13 papers), Cardiac electrophysiology and arrhythmias (12 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Mark L. Bannister is often cited by papers focused on Ion channel regulation and function (13 papers), Cardiac electrophysiology and arrhythmias (12 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Mark L. Bannister collaborates with scholars based in United Kingdom, United States and Australia. Mark L. Bannister's co-authors include Noriaki Ikemoto, Péter Erhardt, Ambrus Tóth, Jaya Gangopadhyay, Shigeki Kobayashi, Christopher H. George, Jerome Parness, Alan J. Williams, Kenneth T. MacLeod and N. Lowri Thomas and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and Biochemistry.

In The Last Decade

Mark L. Bannister

16 papers receiving 589 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark L. Bannister 422 359 116 87 55 17 601
Yehia Marreez 541 1.3× 279 0.8× 98 0.8× 137 1.6× 98 1.8× 8 695
JuFang Wang 459 1.1× 363 1.0× 66 0.6× 33 0.4× 32 0.6× 27 644
Hitoshi Uchinoumi 933 2.2× 990 2.8× 159 1.4× 55 0.6× 34 0.6× 48 1.2k
Cornelia C. Siebrands 300 0.7× 238 0.7× 56 0.5× 64 0.7× 14 0.3× 14 553
Jodene Eldstrom 980 2.3× 916 2.6× 375 3.2× 68 0.8× 25 0.5× 48 1.2k
Felix Wiedmann 445 1.1× 464 1.3× 118 1.0× 16 0.2× 15 0.3× 43 675
Kyoji Urayama 290 0.7× 148 0.4× 55 0.5× 22 0.3× 30 0.5× 14 541
Marie‐Louise Ward 264 0.6× 388 1.1× 63 0.5× 30 0.3× 9 0.2× 44 565
Victor P. Fomin 294 0.7× 92 0.3× 56 0.5× 31 0.4× 41 0.7× 20 511
Stephen Hurst 456 1.1× 53 0.1× 96 0.8× 41 0.5× 57 1.0× 14 613

Countries citing papers authored by Mark L. Bannister

Since Specialization
Citations

This map shows the geographic impact of Mark L. Bannister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Bannister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Bannister more than expected).

Fields of papers citing papers by Mark L. Bannister

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Bannister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Bannister. The network helps show where Mark L. Bannister may publish in the future.

Co-authorship network of co-authors of Mark L. Bannister

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Bannister. A scholar is included among the top collaborators of Mark L. Bannister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Bannister. Mark L. Bannister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hamilton, Shanna, Radmila Terentyeva, Roland Veress, et al.. (2025). Increased Intermembrane Space [Ca 2+ ] Drives Mitochondrial Structural Damage in CPVT. Circulation Research. 137(12). 1385–1403.
2.
Bannister, Mark L., Kenneth T. MacLeod, & Christopher H. George. (2021). Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor. British Journal of Pharmacology. 179(11). 2558–2563. 11 indexed citations
3.
Parthimos, Dimitris, et al.. (2020). Identification of an amino-terminus determinant critical for ryanodine receptor/Ca2+ release channel function. Cardiovascular Research. 117(3). 780–791. 8 indexed citations
4.
George, Christopher H., Alice N. Mitchell, Ryan Preece, Mark L. Bannister, & Zaheer Yousef. (2016). Pleiotropic mechanisms of action of perhexiline in heart failure. Expert Opinion on Therapeutic Patents. 26(9). 1049–1059. 18 indexed citations
5.
Bannister, Mark L., Anita Alvarez‐Laviada, N. Lowri Thomas, et al.. (2016). Effect of flecainide derivatives on sarcoplasmic reticulum calcium release suggests a lack of direct action on the cardiac ryanodine receptor. British Journal of Pharmacology. 173(15). 2446–2459. 13 indexed citations
6.
Bannister, Mark L., N. Lowri Thomas, Markus B. Sikkel, et al.. (2015). The Mechanism of Flecainide Action in CPVT Does Not Involve a Direct Effect on RyR2. Circulation Research. 116(8). 1324–1335. 72 indexed citations
8.
Lyon, Alexander R., Mark L. Bannister, Emma Pearce, et al.. (2011). SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure. Circulation Arrhythmia and Electrophysiology. 4(3). 362–372. 138 indexed citations
9.
Shtifman, Alexander, Christopher W. Ward, Derek R. Laver, et al.. (2008). Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle. Neurobiology of Aging. 31(12). 2080–2090. 54 indexed citations
10.
Tóth, Ambrus, et al.. (2007). Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases. Cardiovascular & Haematological Disorders - Drug Targets. 7(3). 205–218. 107 indexed citations
13.
Bannister, Mark L., Takashi Murayama, Peta J. Harvey, et al.. (2006). Malignant hyperthermia mutation sites in the Leu2442–Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable area. Biochemical Journal. 401(1). 333–339. 18 indexed citations
14.
Bannister, Mark L. & Alan J. Williams. (2004). Activation of the sheep cardiac Ca2+ release channel by simple heteroaromatics. Biochemical and Biophysical Research Communications. 317(2). 397–400. 2 indexed citations
15.
Bannister, Mark L., Alan J. Williams, & Rebecca Sitsapesan. (2004). Removal of clustered positive charge from dihydropyridine receptor II–III loop peptide augments activation of ryanodine receptors. Biochemical and Biophysical Research Communications. 314(3). 667–674. 8 indexed citations
16.
Kobayashi, Shigeki, et al.. (2004). Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor. Journal of Biological Chemistry. 280(8). 6580–6587. 101 indexed citations
17.
Aggeli, Amalia, Mark L. Bannister, Mark Bell, et al.. (1998). Conformation and Ion-Channeling Activity of a 27-Residue Peptide Modeled on the Single-Transmembrane Segment of the IsK (minK) Protein,. Biochemistry. 37(22). 8121–8131. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026